Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,193,469,012
-
Share change
-
+147,239,619
-
Total reported value
-
$117,078,211,628
-
Put/Call ratio
-
110%
-
Price per share
-
$98.18
-
Number of holders
-
2,381
-
Value change
-
+$14,532,143,073
-
Number of buys
-
1,495
-
Number of sells
-
705
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2020
As of 30 Jun 2020,
AbbVie Inc. - Common Stock (ABBV) was held by
2,381 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,193,469,012 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, Nuveen Asset Management, LLC, and Bank of New York Mellon Corp.
This page lists
2,394
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.